Leadership
Team
We are a passionate team of drug developers dedicated to delivering innovative treatments for cancer patients. With over 20 years of combined experience in cutting-edge cancer research, clinical trial design and execution, business development, and management across both biotech and major pharmaceutical companies, we are fully committed to advancing the fight against cancer.
Gary Altman, PhD
CEO and Director
Giovanni Selvaggi, MD
Chief Medical Officer and Director
Terence Walts, MBA
Chief Business Advisor and Director
Taofeek Owonikoko, MD, PhD
Head of SAB and Director
ChiTai Chang, PhD
Director
Calvin Tsai
Director
Gary Altman, PhD
CEO
Swapnaa Balaji, MS, PhD
Staff Scientist
Susan Utt
VP of Operations
Maryam Azeem
Scientist
Taofeek Owonikoko, MD, PhD
Head of SAB
Nikolaos Papadantonakis, MD, M.Sc, PhD
Member of SAB
Susan Thomas, PhD
Member of SAB
John Roback, MD, PhD
Member of SAB
Shanmuganathan Chandrakasan, MD
Member of SAB